Results 141 to 150 of about 848,603 (303)
Abstract Objective To systematically review and synthesize outcomes following sialendoscopy in patients with salivary gland dysfunction and a history of radioactive iodine (RAI). Data Sources A comprehensive search of Medline, Embase, and Cochrane Library was conducted from database inception through December 26, 2025.
Michal Kulasek +2 more
wiley +1 more source
Abstract Mucosal melanomas (MMs) are rare, aggressive cancers with poor outcomes and limited response to standard therapies. A significant knowledge gap exists regarding their genomic landscape and corresponding druggable targets. This study explores this issue through a multi‐omic analysis, including whole exome‐, RNA‐, and targeted sequencing, of ...
Matilde Monti +21 more
wiley +1 more source
Skull base metastasis from papillary thyroid carcinoma: a report of three cases
Mutahir A Tunio,1 Mushabbab Al Asiri,2 Khalid Hussain Al-Qahtani,3 Sadiq Aldandan,4 Khalid Riaz,5 Yasser Bayoumi,6 1Radiation Oncology, King Fahad Medical City, Riyadh, Saudi Arabia; 2Radiation Oncology, Comprehensive Cancer Center, King Fahad Medical ...
Bayoumi Y +5 more
core
Abstract Medullary thyroid carcinoma (MTC) is a neuroendocrine tumor originating from calcitonin producing C‐cells and accounts for 1–5% of thyroid cancers. Total thyroidectomy is curative in localized disease (N0), whereas lymph node metastases (N1) are associated with poorer prognosis.
Anna Citarella +24 more
wiley +1 more source
Papillary thyroid carcinoma is a malignant epithelial tumour showing evidence of follicular cell differentiation and a set of distinctive nuclear features. Papillary thyroid carcinoma is usually invasive.
DeLellis RA +22 more
core +1 more source
Abstract Invasive mucinous adenocarcinoma (IMA) of the lung is a distinct subtype of lung adenocarcinoma with unique clinicopathologic features; however, its histogenesis remains incompletely understood. Although mucinous metaplasia has been suspected as a precursor lesion, direct molecular evidence supporting this progression is limited. In this study,
Joon Young Park +5 more
wiley +1 more source
Encapsulated papillary carcinoma of the breast
Nikolaos S. Salemis +1 more
openaire +2 more sources
BACKGROUND: There is debate about whether interferon-alpha treatment lowers the risk of progression to hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosis and whether any effect is limited to certain subgroups. We investigated
(INTERNATIONAL HEPATOCELLULAR CARCINOMA STUDY GROUP +3 more
core
A novel MCHS‑Au‑LA substrate is developed for carbon‑gold nanostructure‐initiator mass spectrometry (C‑Au‑NIMS), which acquires metabolic fingerprints of serum samples from papillary thyroid carcinoma (PTC), benign thyroid nodules (BTN), and healthy controls (HC).
Wanwan Yi +8 more
wiley +1 more source

